There have been multiple systemic drugs approved for the therapy of psoriasis vulgaris and
psoriasis arthritis (PsA) in the last decade. However, treatment decisions are difficult to make …

The available information about the effects of pregnancy on psoriasis and those of psoriasis
on pregnancy is almost limited, despite the high frequency of the disease in the general …

Psoriasis is an inflammatory skin disorder not uncommonly seen in pregnant patients.
Several drugs have been approved for its treatment in non‐pregnant patients, but special …

Psoriasis is a complex inflammatory disease, and in women the incidence is high in child-
bearing years. Treatment during pregnancy presents genuine challenges since …

Psoriasis is not uncommon in the reproductive years and therefore in pregnant patients.
There are limited data about the impact of psoriasis on the course and prognosis of …

The treatment of psoriasis in pregnant women can be challenging. Psoriasis generally
improves during pregnancy; however, many pregnant patients still require treatment. In …

BACKGROUND: Treating psoriasis in pregnant and lactating women presents a special
challenge. For ethical reasons, prospective randomized control trials have not been …

Biologic agents have become more common to treat patients with psoriasis, but concerns
about their effect on pregnancy and lactation often preclude this treatment during these time …

Psoriasis is a chronic inflammatory disease with a well-documented negative effect on the
quality of life of affected patients. Psoriasis often occurs in the reproductive years, during …

Objective To develop evidence-and experience-based recommendations for the
management of psoriasis during preconception, pregnancy, postpartum, and breastfeeding …